上海谊众公告,2025年上半年营业收入1.6亿元,同比增长31.48%。净利润3800.38万元,同比增长10.13%。报告期内公司营业收入较上年同期增长31.48%,主要原因为核心产品紫杉醇胶束纳入国家医保目录,销量较上年同期显著增长487%。
本文源自:金融界AI电报
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.